Please login to the form below
Avonex
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.
A new dogma in HTA assessment
Novartis faced similar difficulties in the UK when its multiple sclerosis drug Gilenya was declined by the National Institute for Health and Clinical Excellence (NICE) due to its comparator, Avonex, not
Avonex
Avonex campaign. Created by Seven Stones for Biogen Idec. Therapy area: Central Nervous System
Trial finds Sanofi's teriflunomide no better than Rebif
which has the world's largest MS franchise at the moment headed by its Avonex (interferon beta-1a) product.
Genzyme appoints MS and rare diseases business leaders
Sibold has more than 20 years of experience in the biopharmaceutical industry, including eight years at Biogen Idec where he worked on multiple sclerosis products Avonex and Tysabri.
Multiplying options for MS
Recommended pharmacological treatments included one of three interferons (Biogen Idec's Avonex or EMD Serono/Pfizer's Rebif, which are both formulations of interferon ß-1a, or Bayer's Betaseron, an
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK
- GSK signs deal with Medicago for COVID-19 vaccine
- Mesoblast expands compassionate use COVID-19 programme
- Biogen completes filing for highly-anticipated Alzheimer’s drug
- EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug
- GSK and Clover’s COVID-19 vaccine starts clinical trials
- INFOSHEET 01: Use the voice of patients to enhance clinical trial engagement and experiences
- Porter Novelli wins first Best Use of Data Visualisation Award at Communiqué 2020
- Gilead reports remdesivir cuts risk of death in severe COVID-19 patients
- Intelligence that redefines success
- New data reinforces safety profile of Roche’s Hemlibra
- Tecentriq misses the mark in advanced ovarian cancer
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
- We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
- CHECKLIST 04: Let’s make your patient recruitment strategies a success
- From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
- Multichannel engagement and the need for greater understanding of European markets
- By Laurence Olding and Georgina James...
Quick links
Infographics
